Initial Approach to Treating Hyponatremia
The initial approach to treating hyponatremia must prioritize determining symptom severity and volume status, with severely symptomatic patients requiring immediate 3% hypertonic saline to prevent death from cerebral edema, while asymptomatic or mildly symptomatic patients require careful assessment of volume status (hypovolemic, euvolemic, or hypervolemic) to guide appropriate therapy. 1
Immediate Assessment of Symptom Severity
Severely symptomatic hyponatremia is a medical emergency requiring immediate intervention regardless of the underlying cause. 1, 2
- Severe symptoms include seizures, coma, altered mental status, somnolence, obtundation, or cardiorespiratory distress 1, 2, 3
- Mild symptoms include nausea, vomiting, weakness, headache, and mild neurocognitive deficits 3
- Even mild chronic hyponatremia (130-135 mmol/L) should not be ignored, as it increases fall risk (23.8% vs 16.4%), fracture rates, and mortality 1, 2
Emergency Treatment for Severe Symptoms
For severe symptomatic hyponatremia, immediately administer 3% hypertonic saline with a target correction of 4-6 mmol/L over the first 1-2 hours or until symptoms resolve. 1, 2, 3
- Administer 100 mL boluses of 3% saline over 10 minutes, which can be repeated up to three times at 10-minute intervals until symptoms improve 1
- Maximum correction limit: 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2
- US and European guidelines recommend increasing sodium by 4-6 mEq/L within 1-2 hours but no more than 10 mEq/L in the first 24 hours 2
- Monitor serum sodium every 2 hours during initial correction for severe symptoms 1
Volume Status Assessment
After addressing life-threatening symptoms, categorize patients by extracellular fluid volume status to determine appropriate ongoing therapy. 1, 4, 5
Clinical Assessment of Volume Status
- Hypovolemic signs: orthostatic hypotension, dry mucous membranes, decreased skin turgor, tachycardia 1, 6
- Euvolemic signs: no edema, no orthostatic hypotension, normal skin turgor, moist mucous membranes 1
- Hypervolemic signs: peripheral edema, ascites, jugular venous distention, pulmonary congestion 1, 4
Essential Laboratory Workup
Initial diagnostic tests should include: 1, 4
- Serum and urine osmolality
- Urine sodium concentration
- Urine electrolytes
- Serum uric acid
- Assessment of renal function (creatinine, BUN)
Key diagnostic thresholds: 1
- Urine sodium <30 mmol/L suggests hypovolemic hyponatremia (71-100% positive predictive value for response to saline) 1
- Urine sodium >20 mmol/L with high urine osmolality (>500 mOsm/kg) suggests SIADH 1
- Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 1
Treatment Based on Volume Status
Hypovolemic Hyponatremia
Administer isotonic saline (0.9% NaCl) for volume repletion. 1, 3
- Discontinue diuretics immediately 1
- Provide oral fluids if tolerated, or intravenous fluids if needed 1
- Continue isotonic fluids until euvolemia is achieved 1
- Avoid hypotonic fluids, which can worsen hyponatremia 1
Euvolemic Hyponatremia (SIADH)
Fluid restriction to 1 L/day is the cornerstone of treatment. 1, 3, 4
- If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily 1
- For resistant cases, consider vasopressin receptor antagonists (tolvaptan 15 mg once daily) 1, 7
- Alternative pharmacological options include urea, demeclocycline, or lithium (less commonly used due to side effects) 1, 2
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Implement fluid restriction to 1-1.5 L/day for sodium <125 mmol/L. 1, 3
- Temporarily discontinue diuretics if sodium <125 mmol/L 1
- For cirrhotic patients, consider albumin infusion alongside fluid restriction 1
- Avoid hypertonic saline unless life-threatening symptoms are present, as it may worsen edema and ascites 1
- Treat the underlying condition (optimize heart failure management, manage cirrhosis complications) 3
Critical Safety Considerations: Preventing Osmotic Demyelination Syndrome
Never exceed correction of 8 mmol/L in 24 hours for chronic hyponatremia. 1, 2, 4
High-Risk Patients Requiring Slower Correction (4-6 mmol/L per day):
- Advanced liver disease 1
- Alcoholism 1
- Malnutrition 1
- Severe hyponatremia (<120 mmol/L) 1
- Prior encephalopathy 1
If Overcorrection Occurs:
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1
- Consider administering desmopressin to slow or reverse the rapid rise 1
- Target reduction to bring total 24-hour correction to no more than 8 mmol/L 1
Special Considerations for Neurosurgical Patients
In neurosurgical patients, distinguish between SIADH and cerebral salt wasting (CSW), as treatment approaches differ fundamentally. 1, 6
- CSW requires volume and sodium replacement (isotonic or hypertonic saline), NOT fluid restriction 1
- For severe CSW symptoms, administer 3% hypertonic saline plus fludrocortisone in ICU setting 1
- Avoid fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1
- Consider fludrocortisone or hydrocortisone to prevent natriuresis 1
Common Pitfalls to Avoid
- Overly rapid correction exceeding 8 mmol/L in 24 hours leading to osmotic demyelination syndrome 1, 2
- Using fluid restriction in cerebral salt wasting, which worsens outcomes 1
- Inadequate monitoring during active correction 1
- Failing to recognize and treat the underlying cause 1
- Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Ignoring mild hyponatremia (130-135 mmol/L) as clinically insignificant 1